Spotlight on Polyethylene Glycol-Liposomal Doxorubicin in Solid and Hematological Malignancies and AIDS-Related Kaposi's Sarcoma

Author： Sharpe M. Easthope S.E. Keating G.M. Lamb H.M.

Publisher： Adis International

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.2, Iss.1, 2003-01, pp. : 67-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical aspects and management of AIDS-related Kaposi's sarcoma

By Levine A.M. Tulpule A.

European Journal of Cancer, Vol. 37, Iss. 10, 2001-07 ,pp. : 1288-1295

Elsevier

Access to resources Recommend Favorite

Paclitaxel induces apoptosis in AIDS-related Kaposi's sarcoma cells

By Cai Jie Zheng Tong Masood Rizwan Smith D. Lynne Hinton David R. Kim Caryn Nae Fang Guofu Bhalla Kapil Gill Parkash S.

Sarcoma, Vol. 4, Iss. 1-2, 2000-03 ,pp. : 37-45

Informa Healthcare

Access to resources Recommend Favorite

Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin

By Hengge U.R. Esser S. Rudel H.-P. Goos M.

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 878-883

Elsevier

Access to resources Recommend Favorite

Cost-effectiveness Analysis of Pegylated-liposomal Doxorubicin and Liposomal Daunorubicin Treatments in Patients with Kaposi's Sarcoma

By Hjortsberg Catharina Persson Ulf Lidbrink Elisabet Bennett Charles

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1063-1067

Informa Healthcare

Access to resources Recommend Favorite

Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome - determinants of its pathogenicity?

By Cattelan A.M. Calabro' M.L. Aversa S.M.L. Zanchetta M. Meneghetti F. De Rossi A. Chieco-Bianchi L.

European Journal of Cancer, Vol. 35, Iss. 13, 1999-12 ,pp. : 1809-1815

Elsevier

Access to resources Recommend Favorite